Trulieve Cannabis Corp. (NYSE:TRLV – Get Free Report) CEO Kim Rivers sold 300,000 shares of the stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $8.17, for a total value of $2,451,000.00. Following the completion of the transaction, the chief executive officer directly owned 1,613,724 shares in the company, valued at $13,184,125.08. The trade was a 15.68% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Trulieve Cannabis Stock Performance
Shares of Trulieve Cannabis stock traded up $0.06 during trading on Thursday, hitting $8.56. 2,007,316 shares of the company were exchanged, compared to its average volume of 576,130. Trulieve Cannabis Corp. has a 1-year low of $3.50 and a 1-year high of $13.28.
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on the stock. Weiss Ratings initiated coverage on shares of Trulieve Cannabis in a report on Tuesday, June 16th. They issued a “sell (d-)” rating on the stock. Zacks Research raised Trulieve Cannabis to a “hold” rating in a research note on Thursday, June 18th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Reduce”.
Trulieve Cannabis Company Profile
Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.
Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.
See Also
- Five stocks we like better than Trulieve Cannabis
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
